Experiment 67122
Worktypes
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | SC |
| Organism | Empty organism |
| Citation | KANTARJIAN,HM: TALPAZ,M: SMITH,TL: CORTES,J: GILES,FJ: RIOS,MB: MALLARD,S: GAJEWSKI,J: MURGO,A: CHESON,B: O'BRIEN,S:. (2000). HOMOHARRINGTONINE AND LOW-DOSE CYTARABINE IN THE MANAGEMENT OF LATE CHRONIC-PHASE CHRONIC MYELOGENOUS LEUKEMIA.. 18(20) |
| Amount utilized | |
| Compound isolated | |
| Disease | ONE HUNDRED FIVE PATIENTS INCLUDING IN 100 IN CHRONIC PHASE AND FIVE IN ACCELERATED PHASE;THEIR MEDIAN AGE WAS 52 YEARS;PATIENTS WITH PHILADELPHIA CHROMOSOME (PH)-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA. |
| Dose amount | 2.5 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | SQ M |
| Dose expression | DOSE |
| Gender | GIVEN TO BOTH SEXES |